Loading...

WES: Future Investments And Cost Management Will Drive Earnings Amid Market Uncertainty

Published
09 Feb 25
Updated
30 Oct 25
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
21.4%
7D
-11.4%

Author's Valuation

AU$81.640.6% overvalued intrinsic discount

AnalystConsensusTarget Fair Value

Last Update 30 Oct 25

Fair value Decreased 1.06%

Analysts have slightly lowered their price target for Wesfarmers, reducing it from $82.51 to $81.64. They cite modest adjustments to discount rates, revenue growth expectations, and profit margin forecasts as the reasons for this change.

Analyst Commentary

Analysts provided further insight into Wesfarmers' revised price target, evaluating both positive and negative factors impacting the company’s outlook and valuation.

Bullish Takeaways

  • Bullish analysts highlight that Wesfarmers maintains a strong balance sheet, which supports future investments and potential expansion opportunities.
  • Steady consumer demand in core business segments is viewed as a key driver for near-term revenue resilience, even during broader market volatility.
  • Ongoing operational improvements and disciplined cost management are expected to help preserve profit margins, according to optimistic forecasts.
  • Longer-term growth initiatives, particularly in the digital and healthcare arenas, are seen as potentially enhancing the company's earnings trajectory.

Bearish Takeaways

  • Bearish analysts express concern over modest reductions in profit growth expectations, citing increased competition and margin pressures.
  • Uncertainty in the broader economic environment could weigh on discretionary spending, which may affect key business units.
  • Adjustments to discount rates indicate a more cautious approach to future cash flow projections, leading to tempered valuation multiples.
  • Potential regulatory changes or supply chain disruptions remain ongoing risks for the company’s execution.

What's in the News

  • Wesfarmers announced a proposed capital management initiative, including a distribution of $1.50 per share. This consists of a $1.10 capital component and a $0.40 fully-franked special dividend, subject to final approval and an ATO ruling. If approved, payments are expected on December 4, 2025 (AGM announcement).
  • The company declared a fully franked dividend of AUD 1.11 per share for the six months ended June 30, 2025. The ex date is September 2, 2025, with payment scheduled for October 7, 2025 (Company announcement).

Valuation Changes

  • The consensus analyst price target has decreased slightly, moving from A$82.51 to A$81.64.
  • The discount rate has fallen modestly, from 8.07% to 8.00%.
  • Revenue growth expectations have been trimmed, lowering from 4.27% to 4.15%.
  • Net profit margin forecasts have reduced from 6.66% to 6.53%.
  • The future P/E ratio is projected to rise from 34.24x to 34.60x.

Key Takeaways

  • Enhanced digital and omnichannel investments, combined with portfolio optimisation and cost control, are supporting steady growth and operational resilience across core retail segments.
  • Strategic expansion into health and wellness and sustainability initiatives is generating new revenue streams, strengthening brand loyalty, and reducing long-term risk.
  • Rising cost pressures, limited international diversification, execution risks in new ventures, and reliance on cyclical sectors may constrain Wesfarmers' long-term earnings stability and growth.

Catalysts

About Wesfarmers
    Engages in the retail business in Australia, New Zealand, and internationally.
What are the underlying business or industry changes driving this perspective?
  • Stronger investments and execution in omnichannel retail and digital capabilities across Bunnings, Kmart, and Officeworks (including expanded next-day delivery, app usage, and fulfillment centers) are increasing both online and in-store engagement, which should drive higher transaction volumes and support steady revenue and margin growth.
  • Population growth and urbanisation in Australia are expected to fuel demand in home improvement and broader consumer goods, especially benefiting Bunnings and Kmart; Bunnings is poised for a sales and margin uplift as building sector activity recovers, accelerating core revenue and EBIT growth.
  • Expansion into health and wellness through the Priceline Pharmacy network and digital health launches leverages demographic shifts and growing consumer focus on wellness, creating new recurring revenue streams and boosting long-term earnings.
  • Disciplined portfolio actions (wind-down of Catch, divestment of non-core assets, strategic reinvestment in core/adjacent growth areas, and continuous cost control) reduce volatility, unlock capital for higher-return initiatives, and support normalized margin and EPS expansion.
  • Investment in sustainability initiatives (100% renewable energy targets achieved at Bunnings and Officeworks, aggressive Scope 1 and 2 emissions reduction, expanded sustainable product ranges) is improving brand loyalty and lowering future ESG risk, which could reduce risk premia and improve long-term profitability.

Wesfarmers Earnings and Revenue Growth

Wesfarmers Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?
  • Analysts are assuming Wesfarmers's revenue will grow by 4.1% annually over the next 3 years.
  • Analysts assume that profit margins will increase from 6.4% today to 6.7% in 3 years time.
  • Analysts expect earnings to reach A$3.5 billion (and earnings per share of A$3.05) by about September 2028, up from A$2.9 billion today. The analysts are largely in agreement about this estimate.
  • In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 33.5x on those 2028 earnings, down from 34.4x today. This future PE is lower than the current PE for the AU Multiline Retail industry at 34.4x.
  • Analysts expect the number of shares outstanding to remain consistent over the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 8.09%, as per the Simply Wall St company report.

Wesfarmers Future Earnings Per Share Growth

Wesfarmers Future Earnings Per Share Growth

Risks

What could happen that would invalidate this narrative?
  • Persistent cost inflation across labour, supply chain, and rent was repeatedly cited as a key "cost of doing business" challenge for Wesfarmers' retail and industrial divisions; if not offset by productivity gains or pricing power, this could compress net margins and constrain long-term earnings growth.
  • The group's heavy reliance on the Australian and New Zealand markets
  • with little evidence of material international diversification (apart from the nascent Anko Global project)
  • exposes Wesfarmers to local economic cycles, regulatory changes, and structural shifts, potentially leading to revenue and earnings volatility during local downturns.
  • Ongoing execution risk in new verticals and growth platforms, such as the Health division's integration and the Covalent lithium venture, was acknowledged, with current operating losses (e.g., -$59 million in lithium, and limited short-term impact from healthcare initiatives); unsuccessful ramp up or failure to scale these investments could result in future write-downs, lower returns on invested capital, and negative EPS impact.
  • Bunnings' and Kmart's sustained low price positioning leads to continuing price reinvestment ($200 million in Bunnings price spent in FY25) and margin pressure, while lack of clear operating leverage in Bunnings despite modest sales growth raises long-term concerns over efficiency ratios and ability to expand EBIT ahead of revenue growth.
  • The company cited subdued demand from Australian SMEs and ongoing softness in the residential building sector, while also noting that key industrial earnings (e.g., WesCEF, Blackwoods) are highly exposed to volatile global commodity prices and cyclically high input costs (ammonia, gas); this results in unpredictable divisional revenue and profit, impacting group earnings stability and cash flows over time.

Valuation

How have all the factors above been brought together to estimate a fair value?
  • The analysts have a consensus price target of A$80.761 for Wesfarmers based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of A$100.0, and the most bearish reporting a price target of just A$58.0.
  • In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be A$51.6 billion, earnings will come to A$3.5 billion, and it would be trading on a PE ratio of 33.5x, assuming you use a discount rate of 8.1%.
  • Given the current share price of A$88.67, the analyst price target of A$80.76 is 9.8% lower. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives